Immunization of children with inflammatory bowel disease against SARS-CoV-19 infection: A prospective single centre cohort study.
Vaccine X
; 15: 100374, 2023 Dec.
Article
en En
| MEDLINE
| ID: mdl-37822890
ABSTRACT
Background:
Real-world data of children with inflammatory bowel disease (IBD) after SARS-CoV-2 vaccination are needed.Method:
This prospective, observational study evaluate antibody kinetics of children with IBD 6 months after immunization with COVID-19 mRNA vaccine.Results:
24 children with IBD were included, 22 received immunosuppressive treatment. After five weeks the spike protein antibody level was positive in 95% of the cases. After six months all participants had seropositivity results, though the titre was decreasing.Conclusion:
These data show the effectiveness of SARS-CoV2 immunization and the antibody decay over time, that highlight the importance of booster vaccines.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Observational_studies
Idioma:
En
Revista:
Vaccine X
Año:
2023
Tipo del documento:
Article
País de afiliación:
Hungria